Saliva Versus Plasma Therapeutic Drug Monitoring of Valproic Acid in Jordanian Patients
Drug Research · 01.09.2024 · 74 (07) · 314-324
DOI: 10.1055/a-2357-8095 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Drug Research, erschienen am 01.09.2024. Verfasst von Nasir Idkaidek und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical science, Faculty of Pharmacy, Petra University, Amman, Jordan. Hauptthemen laut MEDLINE: Valproic Acid, Drug Monitoring, Saliva. Die Arbeit nennt 10 Literaturangaben.
Abstract (Originalsprache)
Therapeutic drug monitoring is used to ensure that medications are prescribed and administered according to safe doseage advice and for the purpose of achieving the desired therapeutic effects in patients. Several methods are used to perform therapeutic drug monitoring. However, there is insufficient evidence to currently support therapeutic drug monitoring of Valproic acid using salivary samples. The aim of this paper is to determine the feasibility of using salivary samples as a substitute for plasma samples for therapeutic drug monitoring of Valproic acid. In this study a total of 23 patients participated, with the mean age of 33.39. Salivary and plasma samples were collected and analysed to determine the peak and trough concentrations of Valproic acid for comparison between the two methods. Calibrated LC- MS/ MS was used to measure Valproic acid levels. Statistical analyses were performed using ANOVA test and ethical approval was obtained prior to sample collection. The results showed that saliva Valproic acid levels were less than that of plasma levels. There was no significant correlation between saliva and plasma level of Valproic acid (P>0.05). However, there was a significant correlation between the area under the curve for both saliva and plasma Valproic acid (P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical science, Faculty of Pharmacy, Petra University, Amman, Jordan.
- Albasheer Hospital, Amman, Jordan.
- Triumpharma LLC, Amman, Jordan.
Zitieren
APA
Idkaidek, N., Al-Tarawneh, A., Alshoaibi, L., Tuffaha, H., Zinati, A., Abdelqader, M., Al-Ghazawi, A., Rabayah, A., & Hamadi, S. (2024). Saliva Versus Plasma Therapeutic Drug Monitoring of Valproic Acid in Jordanian Patients. Drug Research, 74(07), 314-324. https://doi.org/10.1055/a-2357-8095
Vancouver
Idkaidek N, Al-Tarawneh A, Alshoaibi L, Tuffaha H, Zinati A, Abdelqader M, et al. Saliva Versus Plasma Therapeutic Drug Monitoring of Valproic Acid in Jordanian Patients. Drug Research. 2024;74(07):314-324. doi:10.1055/a-2357-8095
BibTeX
@article{Idkaidek2024,
author = {Idkaidek, Nasir and Al-Tarawneh, Aya and Alshoaibi, Laith and Tuffaha, Haya and Zinati, Asma and Abdelqader, Majed and Al-Ghazawi, Ahmad and Rabayah, Ayman and Hamadi, Salim},
title = {Saliva Versus Plasma Therapeutic Drug Monitoring of Valproic Acid in Jordanian Patients},
journal = {Drug Research},
year = {2024},
volume = {74},
number = {07},
pages = {314--324},
doi = {10.1055/a-2357-8095}
}
EUVIMED